Page 46
Notes:
allied
academies
August 27-28, 2018 | London, UK
International Conference on
Healthcare and Health Management
Cardiology and Cardiac Surgery
Joint Event
&
Journal of Public Health Policy and Planning | Volume: 2
21
st
Century Approach – No average patient: A Noninvasive measuring of drug sensitivity
Maria Kuman
Holistic Research Institute, USA
C
linical research shows that humans have different: drug,
stress, and emotional sensitivity. Usually, the drug-sensitive
individuals are also stress sensitive and emotionally sensitive.
If so, there is no such a thing as an average patient. The dose
for a low-sensitive patient would almost kill the high-sensitive
one by triggering a bouquet of allergic reactions. The presently
existing method for testing drug tolerance (Boston University
School of Medicine) requires ingesting of the drug, which
means the intolerance is detected after the harm is done.
The Holiner’s test of genetic testing is complicated, time
consuming, and does not have the accuracy of our method.
Sensitivity could be measured with the amount of released
neurotransmitters, but this would require blood drawing.
Since the neurotransmitters are electrically charged, we
offer electrical measurements with our sensitive patented
equipment to measure the drug, stress and emotional
sensitivity of patients. The drug tolerance can be tested when
the drug is prescribed; it does not require ingestion, it is fast,
and it is non-invasive. Based on measurements, the patients
would be divided into three basic groups: low, middle, and high
sensitivity and each group would be drug-treated differently.
This article also explains why the mathematical description
of sensitivity would require nonlinear quantum mechanics.
e
:
holisticare@mariakuman.com